共 5 条
- [4] Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen-allergic patients JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (01) : 101 - 109
- [5] A novel approach to specific allergy treatment:: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity JOURNAL OF IMMUNOLOGY, 2004, 172 (11): : 6642 - 6648